# Respiratory System & Pulmonology

## Respiratory Tract Embryology Stages {EPCSA}

- Embryonic
- Pseudoglandular
- Canalicular
- Saccular
- Alveolar

## Lung Volumes and Measurements

|Indices|Methods|
|-|-|
|IRV<br>TV<br>ERV|Spirometry|
|RV|Helium dilution method<br>Plethysmography|

![](../Figures/Lung%20Volumes.png)

## Perfusion and Diffusion Limited Pulmonary Circulation

![](../Figures/Perfusion%20and%20Diffusion%20Limited%20Pulmonary%20Circulation.png)

## Ventilation/Perfusion (V/Q) Ratio

|Ratio|Conditions|
|-|-|
|0|Shunt|
|Low|Lung base|
|High|Lung apex|
|∞|Dead space|

### Shunt (↓ V/Q)

- Anatomic shunt (↑ Q)
  - Intracardiac shunt
  - Pulmonary arteriovenous malformation (AVM)
  - Hepatopulmonary syndrome
- Physiologic shunt (↓ V)
  - Obstructive lung diseases
  - Alveolar lung diseases

### Dead Space (↑ V/Q)

- Pulmonary embolism
- Pulmonary vascular diseases

## Etiology of Increased A-a Gradient

- Interstitial lung diseases
- V/Q mismatch

## Physical Examination Findings

|Finding|Mechanism|Conditions|
|-|-|-|
|Hyperresonant percussion|↓ Density|Pneumothorax<br>Emphysema|
|Dull percussion|↑ Density|Pleural effusion<br>Lung consolidation|
|↓ Fremitus|Accumulation in pleural space|Pleural effusion|
|↑ Fremitus|Accumulation in lung|Lung consolidation|

## Breathing Patterns

![](../Figures/Respiratory%20Patterns.png)

## Etiology of Kussmaul Breathing {KUSSMAUL}

- Ketoacidosis
- Uremia
- Sepsis
- Salicylate
- Methanol
- Aldehyde
- Uricemia
- Lactic acidosis

## Etiology of DLCO Changes

### Decreased DLCO

- Emphysema
- Interstitial lung diseases

### Increased DLCO

- Asthma

## Light Criteria for Pleural Fluid (PF)

|PF|PF ÷ Serum TP|PF ÷ Serum LDH|PF LDH|
|-|-|-|-|
|Transudate|< 0.5|< 0.6|< 2/3 Serum LDH upper limit|
|Exudate|> 0.5|> 0.6|> 2/3 Serum LDH upper limit|

- Total protein (TP)
- Lactate dehydrogenase (LDH)

## Comparison Between Obstructive and Restrictive Lung Diseases

||Obstructive|Restrictive|
|-|-|-|
|TLC|↑|↓|
|FEV<sub>1</sub>|↓|↓|
|FVC|-|↓|
|FEV<sub>1</sub>/FVC|↓|-|

![](../Figures/Comparison%20Between%20Obstructive%20and%20Restrictive%20Lung%20Diseases.png)

## Types of Obstructive Lung Diseases

- Asthma
- Chronic obstructive pulmonary disease (COPD)
  - Chronic bronchitis
  - Emphysema
    - Centriacinar emphysema
    - Panacinar emphysema
- Bronchiectasis
  - Central bronchiectasis
  - Peripheral bronchiectasis

## Etiology of Obstructive Lung Diseases

|Disease|Etiology|
|-|-|
|Asthma|Hypersensitivity|
|Chronic bronchitis|Smoking|
|Centriacinar emphysema|Smoking|
|Panacinar emphysema|α1-antitrypsin deficiency|
|Central bronchiectasis|Allergic bronchopulmonary aspergillosis (ABPA)|
|Peripheral bronchiectasis|Cystic fibrosis<br>Primary ciliary dyskinesia<br>Immunodeficiency|

## Classification of Asthma Severity

|Asthma|Attacks|Awakenings|SABA Uses|FEV<sub>1</sub>|FEV<sub>1</sub>/FVC|
|-|-|-|-|-|-|
|Intermittent|< 2 days/week|≤ 2/month|≤ 2 days/week|> 80%|Normal|
|Mild persistent|2 ~ 7 days/week|3 ~ 4/month|2 ~ 7 days/week|> 80%|Normal|
|Moderate persistent|Daily|> 1/week|Daily|60 ~ 80%|↓ < 0.05|
|Severe persistent|Throughout|Daily|Throughout|< 60%|↓ > 0.05|

## Treatment of Asthma

![](../Figures/Treatment%20of%20Asthma.gif)

## Medications for Asthma

|Mechanism|Medication|
|-|-|
|β<sub>2</sub> agonists|Albuterol<br>Salmeterol<br>Formoterol|
|M antagonists|Ipratropium<br>Tiotropium|
|NF-κB inhibitors|Steroids|
|LOX inhibitors|Zileuton|
|LTD<sub>4</sub> antagonists|Montelukast<br>Zafirlukast|
|Mast cell inhibitors|Cromolyn<br>Nedocromil|
|IgE inhibitors|Omalizumab|

## GOLD Staging of Chronic Obstructive Pulmonary Disease (COPD)

|Stage|Severity|FEV<sub>1</sub>|
|-|-|-|
|1|Mild|> 80%|
|2|Moderate|50 ~ 80%|
|3|Severe|30 ~ 50%|
|4|Very severe|< 30%|

## Types of Pneumoconioses

|Type|Deposit|Location|Findings|Associations|
|-|-|-|-|-|
|Asbestosis|Asbestos|Lung base|Calcified pleural plaques<br>Ferruginous bodies|Bronchogenic carcinoma<br>Mesothelioma|
|Coal worker’s disease|Coal dust|Lung apex|-|-|
|Silicosis|Silica|Lung apex|Eggshell calcifications|Tuberculosis|
|Berylliosis|Beryllium|Hilum|Hilar adenopathy|-|

## Types of Lung Cancers

|Type|Location|Paraneoplastic Syndromes|
|-|-|-|
|Small cell carcinoma|Central|ACTH & SIADH<br>Lambert-Eaton myasthenic syndrome<br>Paraneoplastic myelitis/encephalitis|
|Squamous cell carcinoma|Central|PTHrP|
|Adenocarcinoma|Peripheral|-|
|Large cell carcinoma|Peripheral|β-hCG|

## Modified Wells Criteria for Pulmonary Embolism

|Criteria|Points|
|-|-|
|DVT symptoms/signs|3|
|Clinical suspicion|3|
|Tachycardia|1.5|
|Immobilization|1.5|
|Previous PE/DVT|1.5|
|Hemoptysis|1|
|Malignancy|1|

## Management of Suspected Pulmonary Embolism

|Score|Risk|Management|
|-|-|-|
|0 ~ 1|Low|D-dimer|
|2 ~ 6|Intermediate|CT angiography<br>V/Q scan<br>Bedside echocardiography|
|≥ 7|High|Treatment|

## Evaluation for Pulmonary Embolism

- D-dimer
- CT angiography
- Ventilation/Perfusion (V/Q) scan
- Bedside echocardiography

## Treatment of Pulmonary Embolism

- Anticoagulants
- IVC filter
- Revascularization
  - Thrombolysis
  - Thrombectomy

## Lower Respiratory Tract Infections

|Infection|Pathogens|Management|
|-|-|-|
|Epiglottitis|Haemophilus influenzae|Antibiotics<br>Intubation|
|Laryngotracheobronchitis [Croup]|Parainfluenza virus|Steroids<br>Nebulized epinephrine|
|Bronchitis<br>Bronchiolitis|Virus|Supportive care|
|Pneumonia|Any|Antimicrobials|

## Sputum Sample Acceptable for Gram Stain

- PMNs > 25/HPF
- Epithelial cells < 10/HPF

## Pathogens of Bronchitis & Bronchiolitis

- RSV
- Rhinovirus
- Parainfluenza virus
- Influenza virus
- Adenovirus
- Coronavirus

## Pathogens of Pneumonia

### Lobar Pneumonia & Bronchopneumonia

- Staphylococcus aureus
- Streptococcus pneumonia
- Haemophilus influenzae
- Klebsiella pneumoniae
- Pseudomonas aeruginosa
- Anaerobes
- Viruses

### Atypical Pneumonia {LCM}

- Legionella
- Chlamydia
- Mycoplasma

## Empirical Antibiotics for Pneumonia

|Patient|Antibiotics|
|-|-|
|CAP & Outpatient|Amoxicillin<br>Macrolides / Doxycycline|
|CAP & Outpatient & Complicated|Amoxicillin & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & Inpatient|Anti-pneumococcal β-lactams & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & Inpatient & Complicated|Anti-pneumococcal β-lactams & Fluoroquinolones|
|HAP|Anti-MRSA & Anti-pseudomonal β-lactams & Fluoroquinolones|

### Complicated Outpatients

- Age > 65 years
- Antibiotics within 3 months
- Commorbid

### CURB-65 Score for Inpatient

- Confusion
- Uremia :: BUN > 19
- Respiratory rate > 30
- Blood pressure :: SBP/DBP < 90/60 mm Hg
- Age > 65 years

## Respiratory Failure

|Type|PaO<sub>2</sub>|PaCO<sub>2</sub>|A-a Gradient|Etiology|
|-|-|-|-|-|
|1|↓|-|↑|V/Q mismatch|
|2|↓|↑|-|Hypoventilation|
|3|↓|↑|↑|Mixed|
|4|↓|↑|-|Sepsis|

## Indications for Mechanical Ventilation

- GCS ≤ 8
- PaCO<sub>2</sub> > 50 mmHg
- PaO<sub>2</sub> < 60 mmHg
- SpO<sub>2</sub> < 90%

## Ventilator Modes

|Sequence|Control|Trigger|Mode|
|-|-|-|-|
|Continuous mandatory|Presure (PC)<br>Volume (VC)|Time|Assist-control ventilation (ACV)|
|Intermittent mandatory|Presure (PC)<br>Volume (VC)|Time<br>Patient|Synchronized intermittent mandatory ventilation (SIMV)|
|Continuous spontaneous|-|Patient|Pressure support ventilation (PSV)|

## Etiology of Post-intubation Desaturation {DOPE}

- Displacement
- Obstruction
- Pneumothorax
- Equipment failure

## Ventilation Weaning Parameters

|Parameter|Normal Adult Range|Weaning Threshold|
|-|-|-|
|Respiratory Rate (RR)|14 ~ 18|< 40|
|Tidal Volume (V<sub>T</sub>)|5 ~ 7 mL/kg|5 mL/kg|
|Rapid shallow breathing index (RSBI) = RR ÷ V<sub>T</sub>|< 50/min/L|< 105/min/L|
|PF Ratio = PaO<sub>2</sub> ÷ FiO<sub>2</sub>|> 400|> 200|
|Max Inspiratory Pressure|< -90 cm H<sub>2</sub>O|< -25 cm H<sub>2</sub>O|
